Apex Scientific

21+ access.
Research use only.

Before entering, confirm that you meet the age requirement and understand the research-use limitations that apply to every Apex product.

Your email is used for site access, checkout, account, and order communications. This step does not subscribe you to marketing. Read the Privacy Notice, Research Use Policy, and Terms.

Leave site

Your acknowledgement is remembered on this device for 30 days.

Research use only Clear product information Free shipping on orders over $200 20% launch offer · Use code APEX101
Apex Scientific
Bag 0

Compound guide

TESAMORELIN

From cellular signaling to what those pathways mean in everyday language.

Overview

A Summary:TESAMORELIN

Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH), a peptide signal involved in pituitary growth-hormone release.

Tesamorelin copies growth hormone-releasing hormone, a natural message sent to the pituitary gland. It works upstream by encouraging the body to release growth hormone in pulses and increase downstream IGF-1 signaling.

Inside the body

Cellular & MolecularHow TESAMORELIN Functions

These receptors, enzymes, and signaling networks form the primary steps connecting this compound with changes inside cells and tissues.

01Pituitary activation

GHRH receptor

At the cellular or molecular level

Tesamorelin binds the GHRH receptor on pituitary somatotroph cells. This Gs-coupled receptor raises cyclic AMP, activates protein kinase A, and promotes pulsatile release of growth hormone.

02Liver + tissue response

Growth-hormone receptor

At the cellular or molecular level

Released growth hormone binds its receptor in the liver and other tissues, activating JAK2 and STAT signaling. The liver then increases production of insulin-like growth factor 1, or IGF-1.

03Visceral-fat biology

Adipose signaling

At the cellular or molecular level

Growth-hormone signaling changes how fat cells store and release lipids, including increased lipolytic signaling. Clinical research with the approved formulation focused on visceral abdominal fat in a specific disease-related setting.

In plain English

What those pathways mean.

01

Pituitary activation

The result is a stronger version of the body's own growth-hormone signal rather than a continuous outside supply.

02

Liver + tissue response

GH and IGF-1 influence tissue growth, nutrient handling, and body composition.

03

Visceral-fat biology

That pathway can reduce visceral fat under the studied conditions without making tesamorelin a general-purpose weight-loss treatment.

How the signals work together

Tesamorelin starts a hormone relay. The pituitary releases growth hormone, the liver increases IGF-1, and fat and other tissues change how they handle nutrients. This is a timed endocrine signal rather than a direct supply of growth hormone.

Read the evidence

Sources BehindThis Guide

FDA prescribing information and mechanismTesamorelin identity record

One important note

Educational Notice

Controlled human findings come from a defined tesamorelin medicine studied in adults with HIV-associated lipodystrophy. Those results should be read within that formulation and population.

This guide explains cellular mechanisms and published outcomes in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.